RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer

NCT01058655 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancer

Interventions

DRUG: Everolimus
DRUG: Tivozanib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]